American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID‐19 Pandemic: Version 1

This task force review from the US perspective details 33 guidance statements covering potential therapy and disease monitoring modifications during the COVID-19 pandemic. Document notes that literature on COVID‐19 is rapidly evolving, with future updates anticipated.

Arthritis & Rheumatology